TLIS Talis Biomedical Corporation

At Talis, we strive to deliver excellence in point of care diagnostics by increasing access to timely and accurate testing that can help combat the spread of known and emerging infectious diseases.

$0.53  +0.01 (1.21%)
As of 03/21/2023 16:30:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2021
Outstanding shares:  26,781,915
Average volume:  72,837
Market cap:   $15,991,481
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BLH1HZ6

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%